Business
Cerus Corporation Celebrates World Blood Donor Day 2022
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2022. For over 15 years,

About this update from Cerus Corporation
[{"type":"text","content":" CONCORD, Calif.--(BUSINESS WIRE)--\nCerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2022.\n\nFor over 15 years, World Blood Donor Day has helped served as an annual event to raise awareness of the crucial importance of available blood and blood products for patients around the globe, while also recognizing the generosity of blood donors who make these products available. This year’s campaign, “Donating blood is an act of solidarity. Join the effort and save lives,” highlights the need for donations in support of an adequate blood supply around the world on a year-round basis.\n\n“A blood donation is a selfless yet essential act, as every donation contributes to the provision of critical therapeutic blood components that benefit numerous types of patients in need,” stated William ‘Obi’ Greenman, Cerus’ president and chief executive officer. “With the challenges of managing a complex and time sensitive supply chain, blood centers often struggle with maintaining an adequate inventory of blood products, which can place significant strains on the healthcare system.”\n\nAlthough blood centers everywhere are continuously recruiting for new donors, the pool of available donors remains small and geographically limited. According to the World Health Organization (WHO), more than 118.5 million blood donations are collected annually around the world, with 40% of these donations collected in high-income countries, which contain only 16% of the global population.1 The WHO has stated that, “Blood and blood products are essential resources for effective management of women suffering from bleeding associated with pregnancy and childbirth; children suffering from severe anemia due to malaria and malnutrition; patients with blood and bone marrow disorders, inherited disorders of hemoglobin and immune deficiency conditions; victims of trauma, emergencies, disasters and accidents; as well as patients undergoing advanced medical and surgical procedures.”2\n\n“Since our inception, our singular focus has been on leading with the science to transform the field of transfusion medicine and establish a proactive solution for blood safety and availability,” Greenman continued. “As Cerus celebrates its 30th anniversary in 2022 and we look ahead over the next 30 years, we are committed to continue to be a truste...